General description
NAAG is a neuropeptide and a neurotransmitter that is abundant in the mammalian nervous system. It remains uncertain whether this compound activates NMDA receptors; however, it is clearly demonstrated to act as a selective agonist of mGluR3, both in vitro and in vivo.
Warning
Toxicity: Regulatory Review (Z)
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Other Notes
Neale, J., et al. 2011. J. Neurochem.12, in press; Neal, J., et al. 2011. J. Neurochem.118, 490; Adedoyin, M., et al. 2010. Mol. Pain6, 60; Chopra M., et al. 2009. J. Pharmacol. Exp. Ther.330, 212; Fricker, A., et al. 2009. Neuropharmacology56, 1060; Neale, J.,et al. 2005. Trends Pharmacol. Sci.29, 477; Westbrook, G., et al. 1986. J. Neurosci.11, 3385; Koller, K., et al. 1984. J. Neurochem.43, 1136; Curatolo, A., et al. 1965, J. Neurochem.12, 339.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
- UPC:
- 51141595
- Condition:
- New
- Availability:
- 3-5 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- MPN:
- 481920-50MG
- CAS:
- 3106-85-2
